Human Genome Sciences, Vascular Genetics, Vical deal

The companies will develop products based on genes from HGSI's database using VICL's naked DNA delivery technology. VICL has the option to exclusively license up to three genes from HGSI, and HGSI has the option to license VICL's technology for use in up to three products. Each company will be eligible for royalties on the other's products. ...